Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Background: Painful physical symptoms (PPS) are both common and reduce the likelihood of remission in major depressive disorder (MDD), based upon results of clinical trials in selected populations. Whether PPS significantly contribute to poorer treatment outcome overall in primary or specialty psychiatric care settings remains unclear. Method: Out-patients (n=2876) with MDD were treated in the first step of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial with citalopram up to 60 mg/day for up to 14 weeks. Presence of painful symptoms, as well as severity of depression, physical illness, and demographic and treatment factors were examined. Time to and overall rates of remission were analysed in relation to the presence of PPS. Results: Of the participants, 80% complained of PPS. These patients, both in primary and specialty psychiatric settings, had significantly lower remission rates and took longer to remit. Increasing severity of PPS was associated with greater physical illness burden, lower socio-economic status, absence of private insurance and being female, African-American or Hispanic. After adjustment for these factors, patients with PPS no longer had significantly poorer treatment outcomes. Conclusions: Presence and severity of PPS is an indicator of MDD that may have poorer treatment outcome with an initial selective serotonin reuptake inhibitor. These poorer treatment outcomes are multifactorial, however, and are not explained by the presence and severity of pain per se.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Self-citationRush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829 · cited 12×
“Additional adjustments : HAMD17 remission, gender ; QIDS-SR16 percentage change and QIDS-SR16 response, gender and recurrent depression. comparing those with no PPS to those with the most severe complaints (11.1% difference in remission rates).”
MethodInfluentialSelf-citationThe Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177 · cited 8×
“8 0.4177 QIDS-SR16 response 1343 (46.9) 299 (52.1) 482 (48.4) 348 (46.2) 214 (39.9) Unadjusted OR 0.862 0.788 0.609 0.0005 Adjusted ORc 0.879 0.838 0.688 0.0269 Adjusted ORd 0.888 0.869 0.896 0.6850 Adjusted ORe 0.890 0.867 0.902 0.6866 IDS-C30, 30-Item Inventory of Depressive Symptomatology – clinician-rated ; S.D.,…”
MethodInfluentialSelf-citationAn international study of the relation between somatic symptoms and depression
Simon, G. E., VonKorff, M., Piccinelli, M., Fullerton, C., & Ormel, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910283411801 · Cited by 1,303 · cited 2×
“(Email : afl@ucla.edu) Psychological Medicine (2010), 40, 239–251. f Cambridge University Press 2009 doi:10.1017/S0033291709006035 ORIGINAL ARTICLE symptoms may be a core feature of depressive illness (Simon et al. 1999 ; Bair et al. 2003).”
BackgroundInfluentialSequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076 · cited 6×
“…were guided, however, by length of time at a particular dose, symptom changes and side-effect burden, so that patients with concomitant GMCs, substance abuse/ dependence, other psychiatric disorders or sensitivity to medication side-effects could be titrated more slowly (Rush et al. 2004).”
BackgroundMethodInfluentialSelf-citationBupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., Ritz, L., Biggs, M. M., Warden, D., Luther, J. F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052963 · Cited by 1,033 · cited 13×
“Additional adjustments : HAMD17 remission, gender ; QIDS-SR16 percentage change and QIDS-SR16 response, gender and recurrent depression. comparing those with no PPS to those with the most severe complaints (11.1% difference in remission rates).”
MethodInfluentialSelf-citationMedication Augmentation after the Failure of SSRIs for Depression
Trivedi, M. H., Fava, M., Wisniewski, S. R., Thase, M. E., Quitkin, F., Warden, D., Ritz, L., Nierenberg, A. A., Lebowitz, B. D., Biggs, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052964 · Cited by 1,002 · cited 3×
“After a trial of optimal dose and duration, remitters and responders could enter 12-month naturalistic follow-up, but all who did not remit were encouraged to enter subsequent randomized trials (level 2 of STAR*D) (Rush et al. 2006b ; Trivedi et al. 2006a).”
BackgroundResultSelf-citationTRIVEDI, M. H., RUSH, A. J., IBRAHIM, H. M., CARMODY, T. J., BIGGS, M. M., SUPPES, T., CRISMON, M. L., SHORES-WILSON, K., TOPRAC, M. G., DENNEHY, E. B., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291703001107 · Cited by 968 · cited 2×
“CRCs administered the initial HAMD17 as well as the clinician-rated 16-item Quick Inventory of Depressive Symptomatology (QIDS-C16) and the patient completed the QIDS self-report (QIDS-SR16) (Rush et al. 2000, 2003, 2006a ; Trivedi et al. 2004).”
MethodSelf-citationFava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111868 · Cited by 927
Self-citationRush, A. J., Carmody, T., & Reimitz, P. (2000) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.79 · Cited by 427 · cited 12×
“Additional adjustments : HAMD17 remission, gender ; QIDS-SR16 percentage change and QIDS-SR16 response, gender and recurrent depression. comparing those with no PPS to those with the most severe complaints (11.1% difference in remission rates).”
MethodInfluentialSelf-citation
Cited by
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Kroenke, K., Wu, J., Bair, M. J., Krebs, E. E., Damush, T. M., & Tu, W. (2011) · The Journal of Pain · doi:10.1016/j.jpain.2011.03.003 · Cited by 573
“At least some college or trade school 41 (33) 46 (37) 107 (43)”
BackgroundWarner-Schmidt, J. L., Vanover, K. E., Chen, E. Y., Marshall, J. J., & Greengard, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104836108 · Cited by 291
Impact of pain on the course of depressive and anxiety disorders
Gerrits, M. M. J. G., Vogelzangs, N., van Oppen, P., van Marwijk, H. W. J., van der Horst, H., & Penninx, B. W. J. H. (2012) · Pain · doi:10.1016/j.pain.2011.11.001 · Cited by 199
Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder
Uher, R., Carver, S., Power, R. A., Mors, O., Maier, W., Rietschel, M., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291712000190 · Cited by 45
“For example, chronic painful symptoms could influence both NSAID use and treatment outcome (Leuchter et al. 2010), but the lack of a specific measure of these symptoms precluded a full exploration in the GENDEP sample.”
Background
Metadata
- Authors
- Leuchter, A. F., Husain, M. M., Cook, I. A., Trivedi, M. H., Wisniewski, S. R., Gilmer, W. S., Luther, J. F., Fava, M., & Rush, A. J.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2009-06-03
- Volume
- 40
- Issue
- 2
- Pages
- 239-251
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2141841738
- Cited by
- 98
- References
- 15
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. https://app.cochat.ai/papers/10.1017/s0033291709006035
- The paper
- Leuchter, A. F., Husain, M. M., Cook, I. A., Trivedi, M. H., Wisniewski, S. R., Gilmer, W. S., Luther, J. F., Fava, M., & Rush, A. J. (2010). Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. Psychological Medicine. https://doi.org/10.1017/s0033291709006035
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.